Repeat examination of the medicinal product
Repeat evaluation of a medicinal product - in cases of insufficient justification or incompleteness of the expert commission's conclusion or ethics council, presence of conflicting data, falsification of conclusions of the medicinal product and (or) ethical evaluation, concealment from the authorized federal executive body of grounds for disqualification of an expert due to his interest in the results of the relevant evaluation, presence of information about direct or indirect interference in the process of the relevant evaluation by persons not participating in its conduct but having influenced the process and results of its conduct, the authorized federal executive body shall appoint a repeat evaluation of the medicinal product and (or) ethical evaluation1.
Federal Law No. 61-FZ dated April 12, 2010 "On Circulation of Medicinal Products", as amended on April 12, 2010, Article 25 // RSFSR. 2010. No. 16. Art. 1815. ↩